Patient factors associated with titration of medical therapy in patients with heart failure with reduced ejection fraction: data from the QUALIFY international registry

by Martin R. Cowie, Jakob Schöpe, Stefan Wagenpfeil, Luigi Tavazzi, Michael Böhm, Piotr Ponikowski, Stefan D. Anker, Gerasimos S. Filippatos, Michel Komajda, QUALIFY Investigators
Published 2021-04-01

Discontinuation and non‐publication of heart failure randomized controlled trials: a call to publish all trial results

by Muhammad Shahzeb Khan, Izza Shahid, Nava Asad, Stephen J. Greene, Safi U. Khan, Rami Doukky, Marco Metra, Stefan D. Anker, Gerasimos S. Filippatos, Gregg C. Fonarow, Javed Butler
Published 2021-02-01

Identification of chronic heart failure patients with a high 12-month mortality risk using biomarkers including plasma C-terminal pro-endothelin-1.

by Ewa A Jankowska, Gerasimos S Filippatos, Stephan von Haehling, Jana Papassotiriou, Nils G Morgenthaler, Mariantonietta Cicoira, Joerg C Schefold, Piotr Rozentryt, Beata Ponikowska, Wolfram Doehner, Waldemar Banasiak, Oliver Hartmann, Joachim Struck, Andreas Bergmann, Stefan D Anker, Piotr Ponikowski
Published 2011-01-01

Cardiopoietic stem cell therapy in ischaemic heart failure: long‐term clinical outcomes

by Jozef Bartunek, Andre Terzic, Beth A. Davison, Atta Behfar, Ricardo Sanz‐Ruiz, Wojciech Wojakowski, Warren Sherman, Guy R. Heyndrickx, Marco Metra, Gerasimos S. Filippatos, Scott A. Waldman, John R. Teerlink, Timothy D. Henry, Bernard J. Gersh, Roger Hajjar, Michal Tendera, Stefanie Senger, Gad Cotter, Thomas J. Povsic, William Wijns, for the CHART Program
Published 2020-12-01